ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception

Peptides
Wenjia ZhangMengyuan Zhang

Abstract

ARA 290 is an erythropoietin-derived polypeptide that possesses analgesic and tissue protective effect in many diseases such as diabetes and cancer. The analgesic effect of ARA 290 is mediated by its anti-inflammatory and immunomodulatory functions, or more specifically, by targeting the innate repair receptor (IRR) to down-regulate inflammation to alleviate neuropathic pain. However, whether other mechanisms or pathways are involved in ARA 290-mediated analgesic effect remains elusive. In this study, we are particularly interested in whether ARA 290 could directly target peripheral nociceptors by blocking or influencing receptors in pain sensation. Using calcium imaging, cell culture and behavioral tests, we demonstrated that ARA 290 was able to specifically inhibit TRPV1 channel activity, and relieve the mechanical hypersensitivity induced by capsaicin. Our study suggested that ARA 290 could potentially function as a novel antagonist for TRPV1 channel. This finding would not only contribute to the development of new pain treatment using ARA 290, but also help to improve our understanding of the integration between the immune system and the peripheral nervous system.

References

Dec 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Katharine M WalkerPeter McIntyre
Jul 27, 2007·The Journal of Pharmacology and Experimental Therapeutics·Narender R GavvaJames J S Treanor
Jan 23, 2008·The Clinical Journal of Pain·Helena KnotkovaArpad Szallasi
Aug 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Michael BrinesAnthony Cerami
Mar 20, 2009·Molecular Pharmacology·Joris VriensBernd Nilius
Apr 30, 2009·Annual Review of Neuroscience·Michael CostiganClifford J Woolf
Nov 3, 2010·Nature Neuroscience·Tong LiuRu-Rong Ji
Nov 3, 2010·The Journal of Clinical Investigation·Adrienne E Dubin, Ardem Patapoutian
Mar 12, 2011·Journal of Dental Research·A DiogenesK M Hargreaves
Jul 28, 2012·Nature Neuroscience·Isaac M ChiuClifford J Woolf
Jan 1, 2012·Pharmaceuticals·Michael R BrandtStephen M Stahl

❮ Previous
Next ❯

Citations

Aug 9, 2016·Pain Reports·Albert DahanMonique van Velzen
Feb 2, 2021·Neurochemical Research·Salman HemaniAnna Woodbury
Jul 20, 2021·Journal of Neurochemistry·Daniela C VittoriAlcira B Nesse

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.